share_log

Apogee Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(2.22%),Deep Track Biotechnology Master Fund, Ltd.(2.22%), etc.

Apogee Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Deep Track Capital, LP(2.22%),Deep Track Biotechnology Master Fund, Ltd.(2.22%)等

美股SEC公告 ·  11/14 23:21
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息